Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Recall Of Device For Critically Ill Newborns High-Risk Class I, FDA Says

Executive Summary

The GENOSYL DS Nitric Oxide Delivery System was recalled by Vero Biotech because the device’s software could deliver an incorrect dosage of nitric oxide, a drug used on newborns experiencing respiratory failure.

You may also be interested in...

FDA Warning Letter Recap, July 2021: Device Center Brings Hammer Down On Face Mask Vendors

The US FDA says the 11 companies were selling masks without agency clearance, approval or authorization. A total of 13 device-related missives were released by the FDA in July.

FDA Grants Labelers Of Lower-Risk Devices More Time To Comply With UDI Reg

Labelers of an array of medical devices, from contact lenses to condoms, have been given more time to comply with the US FDA’s eight-year-old Unique Device Identification rule. The agency says labelers of certain products may continue using Universal Product Codes (UPCs) on packaging through September 2023.

COVID-19: FDA Schedules 4 More Virtual Town Halls Through August

The US agency has announced four additional webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the coronavirus.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts